184 related articles for article (PubMed ID: 35278812)
1. Plasma secretome analyses identify IL-8 and nitrites as predictors of poor prognosis in nasopharyngeal carcinoma patients.
Zergoun AA; Draleau KS; Chettibi F; Touil-Boukoffa C; Djennaoui D; Merghoub T; Bourouba M
Cytokine; 2022 May; 153():155852. PubMed ID: 35278812
[TBL] [Abstract][Full Text] [Related]
2. Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
Jin YB; Zhang GY; Lin KR; Chen XP; Cui JH; Wang YJ; Luo W
PLoS One; 2017; 12(2):e0172264. PubMed ID: 28207826
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of serum cytokines in patients with nasopharyngeal carcinoma.
Lu K; Feng X; Deng Q; Sheng L; Liu P; Xu S; Su D
Onkologie; 2012; 35(9):494-8. PubMed ID: 23007146
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.
Cappelletto E; Fasiolo LT; Salizzato V; Piccin L; Fabozzi A; Contato A; Bianco PD; Pasello G; Chiarion-Sileni V; Gion M; Fabricio ASC
Int J Biol Markers; 2024 Mar; 39(1):9-22. PubMed ID: 38407953
[TBL] [Abstract][Full Text] [Related]
5. IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.
Zergoun AA; Zebboudj A; Sellam SL; Kariche N; Djennaoui D; Ouraghi S; Kerboua E; Amir-Tidadini ZC; Chilla D; Asselah F; Touil-Boukoffa C; Merghoub T; Bourouba M
Tumour Biol; 2016 Mar; 37(3):3505-14. PubMed ID: 26453114
[TBL] [Abstract][Full Text] [Related]
6. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival.
Chang KP; Chang YT; Wu CC; Liu YL; Chen MC; Tsang NM; Hsu CL; Chang YS; Yu JS
Head Neck; 2011 Jun; 33(6):886-97. PubMed ID: 21560180
[TBL] [Abstract][Full Text] [Related]
8. Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19.
Körper S; Schrezenmeier EV; Rincon-Arevalo H; Grüner B; Zickler D; Weiss M; Wiesmann T; Zacharowski K; Kalbhenn J; Bentz M; Dollinger MM; Paul G; Lepper PM; Ernst L; Wulf H; Zinn S; Appl T; Jahrsdörfer B; Rojewski M; Lotfi R; Dörner T; Jungwirth B; Seifried E; Fürst D; Schrezenmeier H
Front Immunol; 2022; 13():1008438. PubMed ID: 36275695
[TBL] [Abstract][Full Text] [Related]
9. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
10. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.
Gu J; Huang X; Zhang Y; Bao C; Zhou Z; Jin J
Cytokine; 2021 Feb; 138():155358. PubMed ID: 33183958
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
13. Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
Du YY; Luo DH; Sun XS; Tang LQ; Mai HQ; Chen QY; Zhong JH; Mai DM; Zhang WR; Chen WH; Mo HY
Cancer Med; 2019 Nov; 8(16):6841-6852. PubMed ID: 31513364
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.
Savitri E; Haryana MS
Glob J Health Sci; 2015 Apr; 7(3):364-72. PubMed ID: 25948470
[TBL] [Abstract][Full Text] [Related]
15. Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy.
Obadă O; Pantalon AD; Rusu-Zota G; Hăisan A; Lupuşoru SI; Constantinescu D; Chiseliţă D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888628
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Cheng D; Kong H; Li Y
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):503-9. PubMed ID: 23749058
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.
Lin SJ; Chang KP; Hsu CW; Chi LM; Chien KY; Liang Y; Tsai MH; Lin YT; Yu JS
J Proteomics; 2013 Dec; 94():186-201. PubMed ID: 24080422
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?
Colonetti K; Pinto E Vairo F; Siebert M; Nalin T; Poloni S; Fernando Wurdig Roesch L; Fischinger Moura de Souza C; Cabral Pinheiro F; Vanessa Doederlein Schwartz I
Cytokine; 2023 Feb; 162():156088. PubMed ID: 36462220
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
Ling F; Xu S; Li X; Sun X; Long W
BMC Cancer; 2023 Feb; 23(1):169. PubMed ID: 36803974
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.
Park JH; Kim MY; Choi IS; Kim JW; Kim JW; Lee KW; Kim JS
PLoS One; 2022; 17(10):e0276497. PubMed ID: 36269747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
